Genomewide Gene Expression Profiles of HPV-Positive and HPV-Negative Oropharyngeal Cancer

Authors:

Abstract
Oral cavity and oropharyngeal squamous cell carcinomas (OSCCs) constitute a major public health burden worldwide. Approximately 400 000 new cases of OSCC were diagnosed in 2002, and approximately 200 000 patients died of these cancers.1 The major risk factors for OSCC are cigarette smoking, alcohol consumption, and betel quid chewing. The evidence for human papillomavirus (HPV) as a potential etiologic agent in OSCC was first reported in 1983, when the presence of HPV antigen was shown in oral cancer specimens.2 Subsequent publications showed an association between infection with high-risk types of HPV and OSCC risk.3-6Molecular and epidemiologic studies strongly suggest that HPV-positive OSCC is a distinctive disease entity that differs from HPV-negative OSCC in molecular, histopathologic, and prognostic characteristics,7-10 HPV-positive OSCC (1) being less frequently associated with p53 mutations, (2) occurring primarily in the oropharynx, (3) tending to be poorly differentiated and basaloid subtypes, and (4) having a more favorable disease outcome.7 To understand the molecular mechanisms underlying these 2 entities of OSCC, we examined genomewide gene expression profiles of HPV-positive and HPV-negative OSCC.

This publication has 24 references indexed in Scilit: